Complete response to alectinib following crizotinib in an ALK-positive inflammatory myofibroblastic tumor with CNS involvement

Complete response to alectinib following crizotinib in an ALK-positive inflammatory myofibroblastic tumor with CNS involvement

Inflammatory myofibroblastic tumor (IMT) is a rare entity that affects mostly children and young adults. The lungs are the most frequent primary site. When feasible, surgical resection is the standard of care and it is associated with long-term survival benefit. Metastatic disease is rare, and centr...

Full description

Bibliographic Details
Main Authors: Camila B. Xavier, Felipe S.N.A. Canedo, Fabíola A.S. Lima, Raíssa R. Melo, Luiz Guilherme C.A. Lima, José Flávio G. Marin, Ciro E. Souza, Olavo Feher
Format: Article
Language:English
Published: Elsevier 2021-12-01
Series:Current Problems in Cancer: Case Reports
Subjects:
Lung cancer
Inflammatory myofibroblastic tumor
ALK-rearrangement
Targeted therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S266662192100065X

Internet

http://www.sciencedirect.com/science/article/pii/S266662192100065X

Similar Items